164 related articles for article (PubMed ID: 28922780)
1. Use of Alternative Medicine for Cancer and Its Impact on Survival.
Johnson SB; Park HS; Gross CP; Yu JB
J Natl Cancer Inst; 2018 Jan; 110(1):. PubMed ID: 28922780
[TBL] [Abstract][Full Text] [Related]
2. Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015-2016.
Nilssen Y; Brustugun OT; Eriksen MT; Haug ES; Naume B; Møller B
BMC Cancer; 2020 May; 20(1):488. PubMed ID: 32473650
[TBL] [Abstract][Full Text] [Related]
3. Complementary Medicine, Refusal of Conventional Cancer Therapy, and Survival Among Patients With Curable Cancers.
Johnson SB; Park HS; Gross CP; Yu JB
JAMA Oncol; 2018 Oct; 4(10):1375-1381. PubMed ID: 30027204
[TBL] [Abstract][Full Text] [Related]
4. Disparities in Prostate, Lung, Breast, and Colorectal Cancer Survival and Comorbidity Status among Urban American Indians and Alaskan Natives.
Emerson MA; Banegas MP; Chawla N; Achacoso N; Alexeeff SE; Adams AS; Habel LA
Cancer Res; 2017 Dec; 77(23):6770-6776. PubMed ID: 29187399
[TBL] [Abstract][Full Text] [Related]
5. Socioeconomic position and survival after lung cancer: Influence of stage, treatment and comorbidity among Danish patients with lung cancer diagnosed in 2004-2010.
Dalton SO; Steding-Jessen M; Jakobsen E; Mellemgaard A; Østerlind K; Schüz J; Johansen C
Acta Oncol; 2015 May; 54(5):797-804. PubMed ID: 25761702
[TBL] [Abstract][Full Text] [Related]
6. Decreasing variation in the use of hospice among older adults with breast, colorectal, lung, and prostate cancer.
Lackan NA; Ostir GV; Freeman JL; Mahnken JD; Goodwin JS
Med Care; 2004 Feb; 42(2):116-22. PubMed ID: 14734948
[TBL] [Abstract][Full Text] [Related]
7. Real world duration of curative intent breast, colorectal, non-small cell lung, and prostate cancer treatment.
Wong SK; Hamm J; Shokoohi A; McGahan CE; Ho C
BMC Cancer; 2021 Mar; 21(1):215. PubMed ID: 33653306
[TBL] [Abstract][Full Text] [Related]
8. Time from incident primary cancer until recurrence or second primary cancer: Risk factors and impact in general practice.
Rasmussen LA; Jensen H; Virgilsen LF; Falborg AZ; Møller H; Vedsted P
Eur J Cancer Care (Engl); 2019 Sep; 28(5):e13123. PubMed ID: 31231898
[TBL] [Abstract][Full Text] [Related]
9. Importance of comorbidity in head and neck cancer.
Piccirillo JF
Laryngoscope; 2000 Apr; 110(4):593-602. PubMed ID: 10764003
[TBL] [Abstract][Full Text] [Related]
10. Racial/ethnic disparities in de novo metastases sites and survival outcomes for patients with primary breast, colorectal, and prostate cancer.
Akinyemiju T; Sakhuja S; Waterbor J; Pisu M; Altekruse SF
Cancer Med; 2018 Apr; 7(4):1183-1193. PubMed ID: 29479835
[TBL] [Abstract][Full Text] [Related]
11. Guideline-concordant Care Improves Overall Survival for Locally Advanced Non-Small-cell Lung Carcinoma Patients: A National Cancer Database Analysis.
Ahmed HZ; Liu Y; O'Connell K; Ahmed MZ; Cassidy RJ; Gillespie TW; Patel P; Pillai RN; Behera M; Steuer CE; Owonikoko TK; Ramalingam SS; Curran WJ; Higgins KA
Clin Lung Cancer; 2017 Nov; 18(6):706-718. PubMed ID: 28601387
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil:lymphocyte ratio and intraoperative use of ketorolac or diclofenac are prognostic factors in different cohorts of patients undergoing breast, lung, and kidney cancer surgery.
Forget P; Machiels JP; Coulie PG; Berliere M; Poncelet AJ; Tombal B; Stainier A; Legrand C; Canon JL; Kremer Y; De Kock M
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S650-60. PubMed ID: 23884751
[TBL] [Abstract][Full Text] [Related]
13. Influence of Age on Guideline-Concordant Cancer Care for Elderly Patients in the United States.
Fang P; He W; Gomez DR; Hoffman KE; Smith BD; Giordano SH; Jagsi R; Smith GL
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):748-757. PubMed ID: 28366580
[TBL] [Abstract][Full Text] [Related]
14. Impact of comorbidity on survival by tumour location: Breast, colorectal and lung cancer (2000-2014).
Parés-Badell O; Banqué M; Macià F; Castells X; Sala M
Cancer Epidemiol; 2017 Aug; 49():66-74. PubMed ID: 28586708
[TBL] [Abstract][Full Text] [Related]
15. Factors that determine the treatment for local and regional prostate cancer.
Desch CE; Penberthy L; Newschaffer CJ; Hillner BE; Whittemore M; McClish D; Smith TJ; Retchin SM
Med Care; 1996 Feb; 34(2):152-62. PubMed ID: 8632689
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive medications and survival in patients with cancer: a population-based retrospective cohort study.
Holmes S; Griffith EJ; Musto G; Minuk GY
Cancer Epidemiol; 2013 Dec; 37(6):881-5. PubMed ID: 24075077
[TBL] [Abstract][Full Text] [Related]
17. Older Patients With Early-stage Breast Cancer: Adjuvant Radiation Therapy and Predictive Factors for Cancer-related Death.
Nagar H; Yan W; Christos P; Chao KSC; Nori D; Ravi A
Am J Clin Oncol; 2017 Jun; 40(3):300-305. PubMed ID: 25333731
[TBL] [Abstract][Full Text] [Related]
18. Etiology, prevention, and treatment of breast, prostate, colorectal, and lung cancer.
Mandel JS; Oken M
Minn Med; 1998 May; 81(5):44-6, 71. PubMed ID: 9637858
[No Abstract] [Full Text] [Related]
19. Survival outcomes of secondary cancers in patients with Waldenström macroglobulinemia: An analysis of the SEER database.
Castillo JJ; Olszewski AJ; Kanan S; Meid K; Hunter ZR; Treon SP
Am J Hematol; 2015 Aug; 90(8):696-701. PubMed ID: 25963924
[TBL] [Abstract][Full Text] [Related]
20. Determinants of survival in older cancer patients.
Goodwin JS; Samet JM; Hunt WC
J Natl Cancer Inst; 1996 Aug; 88(15):1031-8. PubMed ID: 8683633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]